Each Pre-filled Syringe contains 0.3 ml Erythropoietin concentrated solution (rDNA) BP 3000 IU.
Erythropoietin is indicated for the treatment of 1.Anemia associated with Chronic Renal Failure, including patients on dialysis (ESRD) and patients not on dialysis.2.Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy. 3. Anemic patients (hemoglobin > 10 to < 13>4. Anemia related to therapy with zidovudine in HIV-infected patients.
Each Pre-filled Syringe contains 0.3 ml Erythropoietin concentrated solution (rDNA) BP 3000 IU.
Erythropoietin is indicated for the treatment of 1.Anemia associated with Chronic Renal Failure, including patients on dialysis (ESRD) and patients not on dialysis.2.Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy. 3. Anemic patients (hemoglobin > 10 to < 13>4. Anemia related to therapy with zidovudine in HIV-infected patients.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.